Page 4 - Quant Rating News Today

We are of the view that the potential returns for investing in China do not justify the risks associated with the political environment. See why we think so.

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.

UiPath is not profitable. A sell rating seems like the easiest and safest choice. Read why we argue the contrarian case and rate PATH stock a Strong Buy.

Popular opinion is bullish on Cabot Corporation in the face of an economic Doom loop. See why we are bearish and see CBT stock as a black swan.

After resisting the bear cycle better than any other sector, energy is now witnessing the same investor panic. Read why investors should consider a contrarian angle with energy investing.

Teucrium operates derivative and futures-based ETFs that allow investors to trade food commodities. Weather disruptions, inflation, and geopolitical tensions; higher grain prices.

Asana's Q2 earnings came in ahead of consensus analyst expectations on both top and bottom lines. Cash burn concerns were put to ease as Asana's CEO bankrolled the company.

AstraZeneca fell by 5.8% in August on a month-on-month basis. Why should you wait for AZN stock valuation to come off a bit than buying right now? Find out.

Western sanctions against the Russian oil and natural gas industries will reshape global energy markets forever.

Zurn Elkay’s numbers are not strong. We believe there is a potential opportunity but not without significant risk of the stock performing badly. Click to read.